Hims & Hers (HIMS) Stock Drops 15% After Quarterly Loss and Sales Miss

AI Summary

Hims & Hers Health (HIMS) stock fell 15% in premarket trading following a disappointing first-quarter performance. The company reported revenue of $608 million, which missed analysts' expectations of $617.5 million. Additionally, Hims & Hers posted a loss per share of $0.40, compared to a profit of $0.20 in the same quarter last year. The firm also cited $33.5 million in restructuring charges due to a pivot toward branded weight-loss medications, affecting overall costs and profitability, which could impact investor confidence.